Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
1997-10-22
pubmed:abstractText
There is a substantial risk of a second cancer for persons with hereditary retinoblastoma, which is enhanced by radiotherapy.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0098-7484
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
278
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1262-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:9333268-Adolescent, pubmed-meshheading:9333268-Adult, pubmed-meshheading:9333268-Case-Control Studies, pubmed-meshheading:9333268-Child, pubmed-meshheading:9333268-Child, Preschool, pubmed-meshheading:9333268-Cohort Studies, pubmed-meshheading:9333268-Dose-Response Relationship, Radiation, pubmed-meshheading:9333268-Eye Neoplasms, pubmed-meshheading:9333268-Female, pubmed-meshheading:9333268-Humans, pubmed-meshheading:9333268-Incidence, pubmed-meshheading:9333268-Infant, pubmed-meshheading:9333268-Male, pubmed-meshheading:9333268-Middle Aged, pubmed-meshheading:9333268-Neoplasms, Radiation-Induced, pubmed-meshheading:9333268-Neoplasms, Second Primary, pubmed-meshheading:9333268-Radiotherapy Dosage, pubmed-meshheading:9333268-Retinoblastoma, pubmed-meshheading:9333268-Risk, pubmed-meshheading:9333268-Sarcoma, pubmed-meshheading:9333268-Statistics as Topic, pubmed-meshheading:9333268-Survival Analysis, pubmed-meshheading:9333268-Survivors, pubmed-meshheading:9333268-Time Factors
pubmed:year
1997
pubmed:articleTitle
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk.
pubmed:affiliation
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Md 20892, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.